Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2020-05-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于公司申报医疗器械注册获得受理的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acceptance of a medical device registration application by a regulatory authority (Jilin Province Drug Administration). It provides details about the product and the registration process stage. The document is short (740 characters) and does not contain financial data, financial results, or detailed report content. It is an official announcement about a regulatory approval process, not a financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-05-29 Chinese
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about receiving an invention patent certificate issued by the Chinese National Intellectual Property Administration. It describes the patent details, its application, and impact on the company. There is no financial data, no mention of financial results, no regulatory filings related to financial performance, no voting results, no management changes, no legal proceedings, or other report types. The document is an official company announcement about intellectual property rights, which does not fit into any specific financial report category. Given the short length (660 characters) and the nature of the content, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other categories.
2020-05-25 Chinese
关于公司获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a medical device registration certificate issued by a regulatory authority (Jilin Province Drug Administration). It details the product name, registration number, validity period, classification, and clinical use. The document emphasizes the impact on the company's product portfolio and market competitiveness but does not contain financial statements, earnings data, or detailed financial analysis. It is a regulatory announcement about a product certification rather than a financial report or management discussion. The document length is short (909 characters), and it is an announcement of a regulatory approval rather than a report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-05-25 Chinese
关于投资设立全资子公司的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about its plan to invest in establishing 30 wholly-owned subsidiaries. It details the investment purpose, the names and capital of the subsidiaries, and the expected strategic benefits and risks. There is no financial data, no mention of a report being attached or published, and no indication of a regulatory filing or certification. The content is about a capital investment and company structure update, specifically about setting up subsidiaries and investment amounts. This fits the definition of a Capital/Financing Update (CAP) as it relates to company fundraising or capital structure changes through new subsidiaries. The document length is short and focused on the investment announcement, not a full financial report or other categories.
2020-05-25 Chinese
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about receiving an invention patent certificate. It includes details about the patent number, inventors, application date, and the strategic importance of the patent to the company. There is no financial data, no mention of financial results, no regulatory filings, or meeting materials. The document is an official announcement about intellectual property, which does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement about a patent grant, which is best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-05-19 Chinese
关于公司申报医疗器械注册获得受理的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acceptance of medical device registration applications by a regulatory authority (Jilin Province Drug Administration). It details the products involved, their clinical uses, and the current stage of the approval process. The document explicitly states that this acceptance will not impact recent performance and that the company will continue to disclose updates. The document is short (1022 characters) and is an announcement of regulatory acceptance rather than a financial report or detailed operational report. It does not contain financial data, management changes, voting results, or other report types. Therefore, it fits best as a Regulatory Filing (RNS), which is a general category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-05-19 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.